| Code | 90390 | ||||||||||
| MA number | 77/0116/05-S | ||||||||||
| Product Form: | tbl 50x6,25 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 77 - SYMPATHOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.05.2005 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Carvedilol-Teva 6,25mg_072017.doc
|
| PIL: |
PIL_Carvedilol-Teva_tbl_03_2022.pdf
|
| Safety feature | Yes |
| Data update: | 16.04.2018 |
